Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey A Carter

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Respiratory Medicine Case Reports|June 23, 2016
Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLCCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Journal of Cancer Research and Clinical Oncology|April 19, 2017
RRx-001 protects against cisplatin-induced toxicitiesBryan Oronsky, Tony R Reid, Christopher Larson, et al.
Expert Opinion on Therapeutic Targets|April 2, 2020
TGF-beta: a master immune regulatorChristopher Larson, Bryan Oronsky, Corey A Carter, et al.
Medical Oncology (Northwood, London, England)|April 27, 2017
A brief review of the management of platinum-resistant-platinum-refractory ovarian cancerBryan Oronsky, Carolyn M Ray, Alexander I Spira, et al.
Journal of General Internal Medicine|March 26, 2015
Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States MilitaryChristina Brzezniak, Sacha Satram-Hoang, Hans-Peter Goertz, et al.
Case Reports in Oncology|July 13, 2016
Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum DoubletsCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Neoplasia (New York, N.Y.)|December 12, 2017
Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A ReviewBryan Oronsky, Patrick Ma, Tony R Reid, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and managementBryan Oronsky, Scott Caroen, Arnold Oronsky, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 28, 2016
The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health SystemJie Lin, Katherine A McGlynn, Corey A Carter, et al.
Oncoimmunology|September 20, 2018
A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs)Christopher Larson, Bryan Oronsky, Gina Varner, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Respiratory Medicine Case Reports|June 23, 2016
Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLCCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Journal of Cancer Research and Clinical Oncology|April 19, 2017
RRx-001 protects against cisplatin-induced toxicitiesBryan Oronsky, Tony R Reid, Christopher Larson, et al.
Expert Opinion on Therapeutic Targets|April 2, 2020
TGF-beta: a master immune regulatorChristopher Larson, Bryan Oronsky, Corey A Carter, et al.
Medical Oncology (Northwood, London, England)|April 27, 2017
A brief review of the management of platinum-resistant-platinum-refractory ovarian cancerBryan Oronsky, Carolyn M Ray, Alexander I Spira, et al.
Journal of General Internal Medicine|March 26, 2015
Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States MilitaryChristina Brzezniak, Sacha Satram-Hoang, Hans-Peter Goertz, et al.
Case Reports in Oncology|July 13, 2016
Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum DoubletsCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Neoplasia (New York, N.Y.)|December 12, 2017
Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A ReviewBryan Oronsky, Patrick Ma, Tony R Reid, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and managementBryan Oronsky, Scott Caroen, Arnold Oronsky, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 28, 2016
The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health SystemJie Lin, Katherine A McGlynn, Corey A Carter, et al.
Oncoimmunology|September 20, 2018
A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs)Christopher Larson, Bryan Oronsky, Gina Varner, et al.
Pageof 6